Joincare Health tau tshaj tawm tsab ntawv tshaj tawm hais tias nws tsis ntev los no tau txaisDaim Ntawv Teev Npe TshuajrauInhalation Budesonide Ncua tsegpom zoo thiab muab los ntawm National Medical Products Administration (NMPA).
Thawj zaug xa thiab hnub lees txais ntawm Lub Tuam Txhab daim ntawv thov rau Inhalation Budesonide Suspension (2 ml: 1 mg) yog Lub Yim Hli 22, 2017, nrog rau tus lej lees paub CYHS1700291 Yue. Cov khoom no feem ntau qhia rau kev kho mob bronchial hawb pob thiab tuaj yeem siv los ua lwm txoj hauv kev los yog txo qhov ncauj steroids.
Cov khoom no yog tsim los ntawm Joincare Health. Budesonide yog ib qho glucocorticoid uas ua rau muaj kev tiv thaiv - mob hawb pob los ntawm cov tshuaj tiv thaiv hauv zos - inflammatory dab. Kev kho qhov nqus pa yog thawj zaug - kab kev kho rau kev tiv thaiv thiab kho cov kab mob ua pa xws li mob hawb pob. Raws li cov tshuaj nqus tau cov tshuaj ua ncaj qha rau ntawm lub ntsws thiab lub ntsws, lawv muaj qhov pib sai, noj tsawg, thiab mob me me thiab muaj kev phiv.
Raws li hnub tim ntawm tsab ntawv tshaj tawm no, Lub Tuam Txhab qhov kev sib sau ncaj qha R & D peev hauv Inhalation Budesonide Suspension (2 ml: 1 mg) tau kwv yees li ntawmRMB 30,672,800.
Budesonide Inhalation Suspension yog Ameslikas tsim thiab tsim los ntawm AstraZeneca, thawj zaug hauv tebchaws United Kingdom hauv xyoo 1991 thiab tau nthuav tawm rau hauv Suav lag luam hauv xyoo 2001.Raws li cov ntaub ntawv txheeb cais thiab kev kwv yees los ntawm IQVIA, lub tsev muag khoom muag tus nqi ntawm Budesonide Inhalation Suspension hauv Suav teb yog kwv yees li.RMB 5.632 billionhauv 2019.
Raws li pom nyob rau hauv lub vev xaib ntawm Lub Chaw Saib Xyuas Tshuaj Ntsuam Xyuas Tshuaj (CDE) ntawm NMPA thiab Xenda Database, txog rau tam sim no, muaj 2 lub tuam txhab tsim khoom hauv tsev (xws li Lub Tuam Txhab) nrog cov khoom pom zoo rau kev lag luam, thiab lwm 3 lub tuam txhab tsim khoom hauv tsev tau xa daim ntawv thov.
